Physician profile
Michael A Rihner
NPI 1831279702
$12,862.64
in general payments reported to CMS, 2019-2025
42 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,701 · 2020: $1,049 · 2021: $6,955 · 2022: $1,304 · 2023: $667 · 2024: $580 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,577.06 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,553.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,425.40 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $484.71 | 2019-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $468.46 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $365.17 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $304.24 | 2019-2023 | Repatha |
| Biotronik INC. | $250.67 | 2022-2023 | Orsiro Mission |
| Boston Scientific Corporation | $219.78 | 2019-2023 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $196.33 | 2025 | Jot Dx, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $196.02 | 2019-2021 | |
| Astellas Pharma US INC | $188.17 | 2019-2021 | |
| Amarin Pharma, INC. | $166.94 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $149.33 | 2024-2025 | Verquvo |
| Medtronic, INC. | $130.17 | 2021-2025 | Symplicity G3 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rihner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.